Skip to main content
S&P 5007,757.17+0.58%DOW52,856.09+0.69%NASDAQ26,702.86+1.05%BTC$84,192.00+1.31%ETH$2,474.04+0.74%GOLD$4,133.80-0.39%OIL$98.06+0.94%
Smart Investors Daily
SID Premium
HK

OTC · HKMPY

Hikma Pharmaceuticals PLC

Healthcare · Drug Manufacturers - Specialty & Generic

$44.49

Up+$0.34 (+0.77%)

Updated Oct 22, 2026, 5:09 AM

SID Score

5.9/10

Composite research score

Smart Money

46/100

Neutral

Market cap
4.58B
P/E ratio
12.27
Dividend yield
3.78%
52-week range
— – —
Volume
100
Avg. volume
4.42K

Price performance · HKMPY

HKMPY price history

1M range · 0 trading sessions · Daily adjusted prices

HKMPY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HKMPY news

The latest Smart Investors Daily articles mentioning HKMPY.

Stock researchCompany · Overview

HKMPY research

Overview

Company profile and research snapshot.

Company profile

HIKMA PHARMS PLC S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
HKMPY recent ratings
DateFirmRatingTarget
Jul 16, 2026CitigroupBuy—
Jun 22, 2026DeutscheBuy—
May 5, 2026JefferiesBuy—
Apr 28, 2026Berenberg BankBuy—
Mar 4, 2026Berenberg BankBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 17, 2026

3 British Biotech Stocks With Market Caps Up To £4 Billion

Britain is spending record sums just to keep its power grid stable, which shows how critical reliable energy and advanced health science have become to the country’s future. That focus on resilience puts British biotechnology shares in an interesting spot, as investors look for sectors tied to essential services rather than discretionary trends. This article highlights three UK-listed biotech stocks from a quality-focused screen that could deserve a closer look. The three stocks in this...

Yahoo · Oct 10, 2026

Top 3 British Biotech Stocks To Watch In October 2026

Big Tech is pouring more than US$700b into AI infrastructure this year, and healthcare is one of the key testing grounds for whether that spending pays off. That puts British biotech shares in an intriguing spot, as companies try to plug AI into drug discovery, diagnostics and clinical workflows. This article highlights 3 UK biotech stocks from our quality screen that could help you gain exposure to that theme. The three stocks highlighted below are only a snapshot of what came out of this...

Yahoo · Oct 2, 2026

Hikma Pharmaceuticals And 2 British Biotech Stocks To Watch

Eurozone inflation recently topped forecasts and hit a three year high, which keeps pressure on central banks and pushes investors toward areas where returns depend more on scientific progress than economic cycles. That spotlight helps British biotech stocks that pair cutting edge research with reasonable balance sheets. This article walks through three of the most interesting UK biotech shares from our screen and explains what makes each worth a closer look. The three British biotech stocks...

Yahoo · Sep 10, 2026

Hikma advances its epinephrine nasal spray with multi-market regulatory filings

Hikma Pharmaceuticals PLC (Hikma, Group) announces that regulatory submissions for its epinephrine nasal spray, being developed for the emergency treatment of allergic reactions (anaphylaxis), have been accepted for review by regulators in the United States, Europe, and the UK. Hikma has also filed a submission for its epinephrine nasal spray in Canada, with plans to expand filings beyond these markets in due course.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By